Analyst Research: Alexza Pharmaceuticals Inc (ALXA.O)

ALXA.O on Consolidated Issue listed on NASDAQ Global Market

2.25USD
23 Oct 2014
Price Change (% chg)

-- (--)
Prev Close
$2.25
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
146,227
52-wk High
$5.93
52-wk Low
$1.99

Search Stocks
Name Age Since Current Position

Thomas King

59 2003 President, Chief Executive Officer, Director

Mark Oki

45 2012 Senior Vice President, Finance, Chief Financial Officer, Secretary, Principal Financial Officer and Principal Accounting Officer

Robert Lippe

49 2014 Chief Operating Officer, Executive Vice President - Operations

James Cassella

59 2012 Executive Vice President - Research and Development, Chief Scientific Officer

Edwin Kamemoto

61 2014 Senior Vice President - Regulatory Affairs
Search Stocks